retatrutide trials weight loss Phase III study demonstrates 30% Weight loss with retatrutide as

This may be more noticeable early in treatment or after a dose change

Can anti-obesity medications be used by all individuals

Ghosh says the injectable GLP-1s out there remain far superior for blood sugar control and weight loss because of the way theyre metabolized

So far, it has been recognized that the concept of combined targeting of gut hormone receptors is also working in humans [1, 2]

But for me as a doctor, what I'm concerned about is that this fat is inflammatory and metabolically active, and it is driving risk for cardiovascular disease type two [00:05:00] diabetes, fatty liver disease

Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review. Clinical Obesity, vol